
("Invinity" or the "Company")
Result of General Meeting
and
Total Voting Rights
|
RESOLUTION |
VOTES FOR* |
VOTES AGAINST |
WITHHELD |
|
|
|
Number of votes |
% |
Number of votes |
Number of votes |
1 |
To authorise the Directors to allot shares |
270,338,340 |
99.96 |
103,221 |
186,495 |
2 |
To approve the disapplication of shareholder pre-emption rights |
265,467,773 |
98.16 |
4,979,953 |
230,330 |
*Any proxy appointments, which gave discretion to the Chairman, have been included in the 'For' votes total.
Admission
Applications have been made to the
Upon Admission, the Enlarged Share Capital is expected to be up to 568,766,867 Ordinary Shares of
The gross proceeds of the Subscription, totalling
Significant Shareholders
Following Admission, the Subscribers will have the following interests in the Company
|
Number of Ordinary Shares Subscribed |
Resultant % of the Issued Share Capital following Admission |
|
64,102,564 |
11.3% |
Next Gen Mobility Limited* |
64,102,564* |
11.3%* |
*
The minority owner of
Other than where defined, capitalised terms in this announcement have the meanings given to them in the Announcement released by the Company at
Stay up to date with news from Invinity. Join the distribution list for the Company's monthly investor newsletter here.
Enquiries:
|
+44 (0)20 4551 0361 |
|
|
|
|
Canaccord Genuity (Nominated Adviser and Joint Broker) |
+44 (0)20 7523 8000 |
|
|
|
|
|
+44 (0)20 3005 5000 |
|
|
Notes to Editors
Invinity's factory-built flow batteries run continually with no degradation for over 30 years, making them suitable for the most demanding applications in renewable energy production. Energy storage systems based on Invinity's batteries are safe, reliable, and economical, and range in size from less than 250 kilowatt-hours to tens of megawatt-hours.
Invinity was created in
To find out more, visit invinity.com, sign up to our monthly Investor Newsletter here or contact Investor Relations on via +44 (0)20 4551 0361 or ir@invinity.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the